| Literature DB >> 33865912 |
Rehan Villani1, Valentine Murigneux2, Josue Alexis3, Seen-Ling Sim1, Michael Wagels4, Nicholas Saunders1, H Peter Soyer5, Laurent Parmentier6, Sergey Nikolaev7, J Lynn Fink1, Edwige Roy1, Kiarash Khosrotehrani8.
Abstract
Little is known regarding the molecular differences between basal cell carcinoma (BCC) subtypes, despite clearly distinct phenotypes and clinical outcomes. In particular, infiltrative BCCs have poorer clinical outcomes in terms of response to therapy and propensity for dissemination. In this project, we aimed to use exome sequencing and RNA sequencing to identify somatic mutations and molecular pathways leading to infiltrative BCCs. Using whole-exome sequencing of 36 BCC samples (eight infiltrative) combined with previously reported exome data (58 samples), we determine that infiltrative BCCs do not contain a distinct somatic variant profile and carry classical UV-induced mutational signatures. RNA sequencing on both datasets revealed key differentially expressed genes, such as POSTN and WISP1, suggesting increased integrin and Wnt signaling. Immunostaining for periostin and WISP1 clearly distinguished infiltrative BCCs, and nuclear β-catenin staining patterns further validated the resulting increase in Wnt signaling in infiltrative BCCs. Of significant interest, in BCCs with mixed morphology, infiltrative areas expressed WISP1, whereas nodular areas did not, supporting a continuum between subtypes. In conclusion, infiltrative BCCs do not differ in their genomic alteration in terms of initiating mutations. They display a specific type of interaction with the extracellular matrix environment regulating Wnt signaling.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33865912 DOI: 10.1016/j.jid.2021.02.760
Source DB: PubMed Journal: J Invest Dermatol ISSN: 0022-202X Impact factor: 8.551